Cryoablation Systems Patents: Who Leads, Where the Gaps Are 2026
Cryoablation systems patents: mapping who owns cryoballoon and refrigerant-delivery claim space
42.7% concentration. The top 5 of 1,203 records in scope account for 514 filings, 42.7% of the field, and the top 10 hold 59.3%. Filings rose to a 2018 peak of 167, then eased to 81 by 2021 and 48 by 2024, a -41% move over that three-year span. 2025 and 2026 figures are still filling in given the typical 18-month publication lag, so the apparent drop in the newest years should not be read as a slowdown yet.
- 1ST JUDE MEDICAL CARDILOGY DIV INC140
- 2BOSTON SCIENTIFIC SCIMED INC116
- 3ADAGIO MEDICAL99
- 4MEDTRONIC IRELAND MFG UNLIMITED CO98
- 5ST JUDE MEDICAL ATRIAL FIBRILLATION DIVISION INC61
See the full cryoablation systems analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about cryoablation systems patents
Who holds the most cryoablation systems patents?
The dataset ranks 100 assignees by patent family count, and the leading assignee holds 140 of the 1,203 records in scope, well ahead of fifth place at 61 and tenth place at 29. The top 5 assignees combined account for 514 records, 42.7% of the field, and the top 10 extend that to 59.3%. That gap between the leader and the rest indicates a clear frontrunner rather than several tightly matched competitors, though roughly 40% of filings still belong to a long tail of smaller entrants.
Is cryoablation patent filing activity growing or slowing down?
Filing activity peaked in 2018 at 167 records and has since declined, with the complete-year figures showing 81 filings in 2021 falling to 48 in 2024, a -41% change over that span. Publication typically lags filing by about 18 months, so the lower counts shown for 2025 and 2026 are incomplete rather than evidence of a continued drop. A fair read of the trend should stop at the last complete year, 2024, rather than the most recent published figures.
What technology areas do cryoablation patents cover most heavily?
A61B, the diagnosis and surgery classification, appears in 92.7% of the 1,203 records in scope, making it the dominant technical category by a wide margin. A61M fluid-delivery devices (25.6%) and A61N electrotherapy (19.9%) are the next most common overlaps, reflecting how cryoballoon catheters combine mechanical delivery with therapeutic energy elements. Smaller categories like F25D refrigeration hardware (2.2%) and G16H healthcare informatics (2.0%) appear far less often, pointing to less-crowded claim space in cooling-unit design and software-driven procedure support.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Cryoablation Systems covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.